Benzinga | Aug 6, 2020 08:13AM EDT

ANI Pharmaceuticals Q2 Adj. EPS $0.69 Misses $1.00 Estimate, Sales $48.47M Miss $48.93M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $0.69 per share which missed the analyst consensus estimate of $1.00 by 31 percent. This is a 52.08 percent decrease over earnings of $1.44 per share from the same period last year. The company reported quarterly sales of $48.47 million which missed the analyst consensus estimate of $48.93 million by 0.94 percent. This is a 10.83 percent decrease over sales of $54.36 million the same period last year.